Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes

European Journal of Pediatrics

Volumn 159, Issue 7, 2000, Pages 483-488

  Mortensen, Henrik B ^a   Lindholm, Anders ^b   Olsen, Birthe S ^a   Hylleberg, Birgitte ^b  

^a Rigshospitalet   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Children; Insulin analogue; Insulin aspart; Pharmacokinetics; Type 1 diabetes

Indexed keywords

INSULIN;

ABSORPTION; ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0033935859     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051315     Document Type: Article

References (28)

1. 1. Berg TJ, Clausen JT, Torjesen PA, Dahl-Jørgensen K, Bangstad H-J, Hanssen KF (1998) The advanced glycation end product N(ε)-(carboxymethyl)lysine is increased in serum from children and adolescents with type 1 diabetes. Diabetes Care 21: 1997-2002
2. 2. Brange J, Owens DR, Kang S, Vølund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13: 923-954
3. 3. Brange J, Ribel U, Hansen JF, Dodson G, Hansen MY, Havelund S, Melberg SG, Norris F, Nooris K, Snel L, Sörensen AR, Voigt HO (1988) Monomeric insulins obtained by protein engineering and their medical implications. Nature 333: 679-682
4. 4. Brange J, Vølund A (1999) Insulin analogs with improved pharmacokinetic profiles. Adv Drug Deliv Rev 35: 307-335
5. 5. Danne T, Kordonouri O, Hövener G, Weber B (1997) Diabetic angiopathy in children. Diabetic Med 14: 1012-1025
6. 6. Dimitriadis GD, Gerich JE (1983) Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6: 374-377
7. 7. Drejer K (1992) The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diab Metab Rev 8: 259-286
8. 8. Heinemann L, Heise T, Jorgensen LN, Starke AAR (1993) Action profile of the rapid acting insulin analogue: human insulin B28Asp. Diabet Med 10: 535-539
9. 9. Heinemann L, Kapitza C, Starke AAR (1996) Time-action profile of the insulin analogue B28Asp. Diabet Med 13: 683-687
10. 10. Heinemann L, Starke AAR, Hohmann A, Berger M (1992) Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Hormone Metab Res 26[Suppl]: 137-139
11. 11. Heinemann L, Weyer C, Rave K, Stiefelhagen O, Rauhaus M, Heise T (1997) Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp. Exp Clin Endo Diabet 105: 140-144
12. 12. Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM (1998) Diabetic retinopathy in pediatric patients with type 1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr 132: 790-794
13. 13. Home PD, Barriocanal L, Lindholm A (1999) Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers. Eur J Clin Pharm 55: 199-203
14. 14. Home PD, Lindholm A, Hylleberg B, Round P (1998) Improved glycemic control with insulin aspart. Diabetes Care 21: 1904-1909
15. 15. Kaas Ibsen K (1981) Blood pressure in Danish children and adolescents. Acta Paediatr Scand 70: 27-31
16. 16. Kang S, Creagh FM, Peters JR, Brange J, Vølund A, Owens DR (1991) Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9; GluB27; AspB10; AspB28) on meal related plasma glucose excursions in type 1 diabetic subjects. Diabetes Care 14: 571-577
17. 17. Lean MEJ, Ng LL, Tennison BR (1985) Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. BMJ 290: 105-18
18. 18. Lindholm A, McEwen J, Riis A (1999) Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care 22: 801-805
19. 19. Mortensen HB, Hougaard P (1996) Microvascular complications in childhood. In: Shield PH, Baum JD (eds) (Bailliére's Clinical Paediatrics, vol 4, Bailliére Tindall, London, pp 641-661
20. 20. Mortensen HB, Hougaard P for the Hvidøre Study Group on Childhood Diabetes (1997) Comparison of metabolic control in a cross-sectional study of 2873 children and adolescents with insulin-dependent diabetes from 18 countries. Diabetes Care 20: 714-720
21. 21. Mortensen HB, Robertson KJ for the Hvidøre Study Group on Childhood Diabetes (1998) Insulin management and metabolic control of type 1 diabetes in childhood and adolescence in 18 countries. Diabetic Med 15: 752-759
22. 22. Rabasa-Lhoret R, Ducros F, Bourque J, Chiasson JL (1998) Glucose homeostasis during a post-prandial exercise in intensively-treated type 1 diabetics (Db1) subjects treated with the basal-bolus insulin regimen (Ultralente-Lispro) (abstract). Diabetologia 41[Suppl 1]: A16
23. 23. Robinson-Pleadwell M, Morrical L, Hillis S, Strack T, Bailey G (1998) A comparison of glucose and insulin excursions after insulin lispro or Humulin R followed by moderate exercise (abstract). Diabetologia 41[Suppl 1]: A16
24. 24. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977-86
25. 25. The Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr 125: 177-188
26. 26. Torlone E, Pampanelli S, Lalli C, Sindaco PD, Vincenzo AD, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli G (1996) Effects of the short-acting insulin analog (Lys(B28), Pro(B29)) on post-prandial blood glucose control in IDDM. Diabetes Care 19: 945-952
27. 27. WHO Prevention of diabetes mellitus. Report of a WHO Study Group (1994) WHO Technical Report Series 844: 11-13
28. 28. Witt MF, White NH, Santiago JV (1983) Roles of site and timing of the morning insulin injection in type I diabetes. J Paediatr 103: 528-533